Shanghai Hile Bio-Technology Co., Ltd. (SHA:603718)
4.670
+0.050 (1.08%)
At close: Mar 30, 2026
SHA:603718 Market Cap
SHA:603718 has a market cap or net worth of 3.01 billion as of March 30, 2026. Its market cap has decreased by -35.43% in one year.
Market Cap
3.01B
Enterprise Value
2.72B
Revenue
246.35M
Ranking
n/a
PE Ratio
17.42
Stock Price
4.67
Market Cap Chart
Since May 15, 2015, SHA:603718's market cap has increased from 2.75B to 3.01B, an increase of 9.65%. That is a compound annual growth rate of 0.85%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 30, 2026 | 3.04B | -23.88% |
| Dec 31, 2025 | 4.00B | -12.02% |
| Dec 31, 2024 | 4.55B | -35.48% |
| Dec 29, 2023 | 7.05B | 11.42% |
| Dec 30, 2022 | 6.32B | -35.82% |
| Dec 31, 2021 | 9.85B | 21.33% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Shanghai Shen Lian Biomedical | 3.40B |
| Beijing Kawin Technology Share-Holding | 3.25B |
| Landfar Bio-medicine | 3.24B |
| Shanghai Model Organisms Center | 3.09B |
| Guangdong VTR Bio-Tech | 3.04B |
| Cabio Biotech (Wuhan) | 3.04B |
| Jiangsu Sihuan Bioengineering | 3.04B |
| Suzhou Fushilai Pharmaceutical | 2.85B |